Recruiting Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis NCT06047379 Conditions Adenocarcinoma, Astrocytoma, Brain Diseases, +93 more Locations Precision NextGen Oncology — Beverly Hills, California, United States OPN Healthcare, Inc — Glendale, California, United States University of Southern California — Los Angeles, California, United States MDR Core Network — Boynton Beach, Florida, United States View more locations Show fewer locations Loading locations... View Trial Details
Recruiting Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies NCT04114136 Conditions Adenocarcinoma, Adenocarcinoma Of Esophagus, Carcinoma, +28 more Locations UPMC Hillman Cancer Center — Pittsburgh, Pennsylvania, United States View Trial Details
